Stromal cell therapy is a promising frontier in lupus research, especially for people whose lupus doesn’t respond to other treatments (called refractory lupus). We were the first lupus organization in ...

Court documents outline how a former sheriff's deputy allegedly misled and stole from his family and colleagues before ...

It is] interesting work that further highlights the complex intercellular crosstalk between stromal cells in cancer,” said ...

Ono Pharmaceutical will pay $25.60 per share in an all-cash deal to buy Deciphera Pharmaceuticals for its potential ...

The wide adoption of genetic engineering techniques in the late 1990’s played an important role in demonstrating the complexity and importance of communication between stromal cells and immune ...

Herpes stromal keratitis (HSK) is a potentially blinding disease caused by herpes simplex virus corneal infection. Most cases of HSK are due to reactivation of the virus from latency leading to ...

Blueprint Medicines Corporation BPMC reported first-quarter 2024 adjusted loss of $1.32 per share, narrower than the Zacks ...

Collaboration is designed to accelerate the clinical progression of the next generation of cell and exosome therapeutics.

He also highlights the material contribution of advanced Systemic Mastocytosis (ASM) and Gastrointestinal Stromal Tumors (GIST) patients to the sales boost, particularly because these groups could be ...

GSK said in the first quarter of 2024, the sales of Specialty Medicines increased, driven by strong HIV and Oncology ...

Fintel reports that on April 30, 2024, JMP Securities downgraded their outlook for Deciphera Pharmaceuticals (NasdaqGS:DCPH) ...